Duquesne's billionaire boss bid adieu to Wall Street's hottest artificial intelligence (AI) stock in favor of one of the cheapest pharmaceutical stocks on the planet.

Palantir Technologies faced a sharp decline this week. Shares plummeted over 9% on Tuesday, marking a fifth consecutive day ...

Shares of Palantir (PLTR) dropped over 9% on Tuesday due to a critical report from short-selling firm Citron Research, which ...

Shares in Palantir fell as much as 9% in late trading on Tuesday amid a broad AI pullback and a critical short-seller report.

Palantir shares tumbled Tuesday afternoon, extending recent losses as a high-profile short seller fueled worries the stock ...

Major U.S. equities indexes were mixed Tuesday as tech sector losses weighed on their performance. The S&P 500 ended the ...

However, since hitting a record closing high of $186.97 on August 12, the stock on Tuesday was on track for a five-day losing ...

Then, short seller Andrew Left of Citron Research said PLTR stock was "detached from fundamentals and analysis". He's ...

Now, it’s worth noting Stock Advisor’s total average return is 1,076% — a market-crushing outperformance compared to 184 % ...

The Dow is confidently in the black and scored a record high, while the Nasdaq is moving lower as tech stocks struggle ...

Palantir Technologies Inc PLTR is trading lower on Tuesday as selling pressure and weaker momentum indicators weighed on ...

Palantir Q2 results highlight strong growth and margins with 50% YoY potential. Read more on risks like data reliance and ...